BeStock  
Stocks › Biotechnology › SPTX

Seaport Therapeutics SPTX

US equityMarket cap rank #3190Biotechnology
$18.05 −$0.27 (-1.47%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $18.05 0.00%
Open$18.02
Prev close$18.32
Day range$17.41 – $18.83
Volume284.3K
Market cap$966.23M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00
Operating profit-$30.35M-19.3% YoY
Net profit-$26.39M-17.1% YoY
Diluted EPS-$0.49-15.3% YoY
Free cash flow-$22.68M-43.8% YoY
Operating cash flow-$22.68M

Revenue, last 7 quarters

$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$0.0Sep '26

Net profit, last 7 quarters

$-13.1MMar '25$-15.1MJun '25$-22.5MSep '25$-24.1MDec '25$-25.4MMar '26$-62.6MJun '26$-26.4MSep '26

Diluted EPS by quarter

-0.34Mar '25-0.39Jun '25-0.43Sep '25-0.46Dec '25-0.48Mar '26-1.78Jun '26-0.49Sep '26

Free cash flow by quarter

$-20.3MMar '25$-15.6MJun '25$-15.8MSep '25$-26.7MDec '25$-20.2MMar '26$-26.1MJun '26$-22.7MSep '26

Profitability & balance sheet

Return on equity-34.9%
Return on assets-33.2%
Return on invested capital-36.2%
Current ratio17.48
Liabilities / assets4.8%
Cash & investments$290.43M
Total debt$3.06M
Net cash (debt)$287.37M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 Q4 2025 ANNUAL
Operating Cash Flow -$22.68M -$26.14M -$20.17M -$26.65M -$77.94M
Effect of Exchange Rate Changes -$5,000.00 $29,000.00 -$28,000.00 -$28,000.00 $3,000.00
Beginning Cash Balance $64.68M $53.36M $46.50M $46.39M $309.55M
Net Change in Cash -$2.67M $11.29M $6.90M $136,000.00 -$263.06M
Ending Cash Balance $62.01M $64.68M $53.36M $46.50M $46.50M
Proceeds from Stock Option Exercised $0.00 – – $0.00 $1,000.00
Net Common Stock Issuance -$97,000.00 – – – –
Net Cash Flow from Continuing Financing Activities -$97,000.00 $240.93M -$783,000.00 -$874,000.00 -$873,000.00
Financing Cash Flow -$97,000.00 $240.93M -$783,000.00 -$874,000.00 -$873,000.00
Free Cash Flow -$22.68M -$26.14M -$20.17M -$26.67M -$78.30M
Net Investment Purchase and Sale $20.11M -$203.50M $27.85M $27.68M -$183.89M
Net PPE Purchase and Sale $0.00 $0.00 $0.00 -$25,000.00 -$356,000.00
-Change in Prepaid Assets $247,000.00 -$2.00M $1.57M -$1.73M -$6.21M
Net Income from Continuing Operations -$26.39M -$62.60M -$25.41M -$24.14M -$74.88M
Depreciation & Depletion & Amortization $358,000.00 $351,000.00 $357,000.00 $364,000.00 $1.41M
Change in Working Capital $1.45M -$396,000.00 $2.53M -$4.14M -$7.93M
Net cash flow from continuing operations -$22.68M -$26.14M -$20.17M -$26.65M -$77.94M
-Change in Payables and Accrued Expense $1.54M $1.94M $1.29M -$1.76M $877,000.00
-Change in Other Current Assets $0.00 $0.00 $0.00 -$365,000.00 -$1.56M
-Change in Other Current Liabilities -$330,000.00 -$329,000.00 -$323,000.00 -$285,000.00 -$1.04M
Net Cash Flow from Continuing Investing Activities $20.11M -$203.50M $27.85M $27.66M -$184.25M
Net cash flow from investing $20.11M -$203.50M $27.85M $27.66M -$184.25M
Net Other Financing Charges – – -$783,000.00 – -$874,000.00
Gain/Loss from Continuing Operations – – – – $11,000.00
Net Preferred Stock Issuance – – – – $0.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Other Non-Current Assets $454,000.00 $454,000.00 $3.84M $2.88M $2.88M
Total Liabilities $20.17M $19.08M $343.29M $341.55M $341.55M
Total Current Liabilities $17.11M $15.67M $14.22M $12.78M $12.78M
Payables $7.27M $5.71M $4.80M $2.01M $2.01M
-Accounts Payable $5.81M $5.71M $4.79M $2.01M $2.01M
-Total Tax Payable $1.45M – – – –
-Due to Related Parties Current $0.00 $0.00 $11,000.00 $7,000.00 $7,000.00
Current Accrued Expenses $3.97M $5.29M $6.11M $3.94M $3.94M
Short-Term Debt and Capital Lease Obligation $1.62M $1.61M $1.60M $1.64M $1.64M
-Current Capital Lease Obligation $1.62M $1.61M $1.60M $1.64M $1.64M
Total Non-Current Liabilities $3.06M $3.41M $329.07M $328.77M $328.77M
Investments and Advances $113.37M $153.95M $30.04M $17.67M $17.67M
-Accumulated Depreciation -$1.07M -$1.04M -$1.02M -$989,000.00 -$989,000.00
-Gross PPE $5.81M $6.14M $6.47M $6.21M $6.21M
Total Assets $417.62M $441.68M $227.67M $249.01M $249.01M
Total Current Assets $299.06M $282.18M $188.34M $223.23M $223.23M
Cash and Cash Equivalents & Short-Term Investments $290.43M $273.31M $182.61M $215.98M $215.98M
-Cash and Cash Equivalents $61.55M $64.22M $52.91M $46.04M $46.04M
-Short Term Investments $228.88M $209.09M $129.70M $169.94M $169.94M
Receivables $4.72M $4.86M $3.28M $3.03M $3.03M
-Accrued Interest Receivable $2.40M $2.72M $1.38M $1.73M $1.73M
-Taxes Receivable $2.33M $2.14M $1.89M $1.30M $1.30M
Prepaid Assets $3.91M $4.01M $2.46M $4.22M $4.22M
Total Non-Current Assets $118.56M $159.51M $39.33M $25.78M $25.78M
Net PPE $4.74M $5.10M $5.45M $5.23M $5.23M
Long Term Debt and Capital Lease Obligation $3.06M $3.41M $3.74M $3.44M $3.44M
-Long Term Capital Lease Obligation $3.06M $3.41M $3.74M $3.44M $3.44M
Convertible preferred securities $0.00 $0.00 $325.33M $325.33M $325.33M
Total Equity $397.46M $422.60M -$115.62M -$92.55M -$92.55M
Stockholders' Equity $397.46M $422.60M -$115.62M -$92.55M -$92.55M
Capital Stock $5,000.00 $5,000.00 $1,000.00 $1,000.00 $1,000.00
-Common Stock $5,000.00 $5,000.00 $1,000.00 $1,000.00 $1,000.00
-Preferred Stock $0.00 – – – –
Additional Paid-In Capital $627.64M $625.19M $23.83M $21.26M $21.26M
Retained Earnings -$228.51M -$202.12M -$139.52M -$114.11M -$114.11M
Gains/Losses Not Affecting Retained Earnings -$1.68M -$475,000.00 $64,000.00 $301,000.00 $301,000.00

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Profit from Continuing Operations -$26.39M -$62.60M -$25.41M -$74.88M -$24.14M
Net Profit -$26.39M -$62.60M -$25.41M -$74.88M -$24.14M
Tax $127,000.00 $251,000.00 $519,000.00 $773,000.00 $513,000.00
Pretax Profit -$26.27M -$62.35M -$24.89M -$74.11M -$23.62M
Other Non-Operating Income (Expenses) $178,000.00 $202,000.00 $521,000.00 $1.78M $1.06M
Other Income (Expense) $178,000.00 $202,000.00 $521,000.00 $1.78M $1.06M
Non-Operating Interest Income $3.90M $3.26M $2.13M $11.40M $2.52M
Research & Development $23.89M $24.62M $21.43M $66.31M $21.92M
-General & Admin Expense $6.45M $41.19M $6.11M $20.98M $5.28M
Selling and Admin Expenses $6.45M $41.19M $6.11M $20.98M $5.28M
Operating Expense $30.35M $65.81M $27.54M $87.29M $27.20M
Net Income to Parent Company -$26.39M -$62.60M -$25.41M -$74.88M -$24.14M
Net Income to Common Stockholders -$26.39M -$62.60M -$25.41M -$74.88M -$24.14M
Basic EPS -$0.49 -$1.78 -$0.48 -$1.94 -$0.46
Diluted EPS -$0.49 -$1.78 -$0.48 -$1.94 -$0.46
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Profit -$30.35M -$65.81M -$27.54M -$87.29M -$27.20M
Net Non-Operating Interest Income (Expense) $3.90M $3.26M $2.13M $11.40M $2.52M

Discussion

No comments yet — be the first to weigh in on SPTX.

Sign in to join the discussion.

Scroll to Top